| |
| |
|
| Insider
Information: |
Wicki Andreas |
| Relationship: |
Director |
| City: |
Grand Cayman, Cayman Isla |
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
2,599,267 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$13,747,329 |
|
|
| Total
Shares |
2,599,267 |
|
|
| Total
Value |
$13,747,329 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -122.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
|
0 |
2021-03-15 |
451,324 |
Premium* |
|
|
Viela Bio, Inc. |
VIE |
Director |
2019-10-07 |
0 |
2021-03-13 |
0 |
Premium* |
|
|
Harmony Biosciences Holdings, Inc. |
HRMY |
Director |
2021-11-15 |
0 |
2022-12-14 |
2,147,943 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-06-03 |
4 |
S |
$30.00 |
$57,000 |
I/I |
(1,900) |
2,136,374 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-06-04 |
4 |
S |
$30.31 |
$394,030 |
I/I |
(13,000) |
2,123,374 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-06-05 |
4 |
S |
$30.00 |
$75,000 |
I/I |
(2,500) |
2,120,874 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-06-10 |
4 |
S |
$30.00 |
$75,000 |
I/I |
(2,500) |
2,118,374 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-06-11 |
4 |
S |
$30.00 |
$270,000 |
I/I |
(9,000) |
2,109,374 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-06-12 |
4 |
S |
$30.00 |
$132,270 |
I/I |
(4,409) |
2,104,965 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-09-11 |
4 |
S |
$37.25 |
$662,417 |
I/I |
(17,783) |
1,692,194 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2014-03-05 |
4 |
S |
$80.16 |
$1,818,651 |
I/I |
(22,687) |
1,669,507 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2014-03-06 |
4 |
S |
$80.11 |
$176,244 |
I/I |
(2,200) |
1,667,307 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2014-08-08 |
4 |
S |
$101.00 |
$8,292,108 |
I/I |
(82,100) |
1,245,307 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2014-08-11 |
4 |
S |
$101.20 |
$6,894,905 |
I/I |
(67,900) |
1,177,407 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2014-08-25 |
4 |
S |
$108.07 |
$3,241,983 |
I/I |
(30,000) |
1,147,407 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2014-08-26 |
4 |
S |
$108.11 |
$2,617,016 |
I/I |
(24,207) |
1,123,200 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2014-08-27 |
4 |
S |
$108.05 |
$173,535 |
I/I |
(1,606) |
1,121,594 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2014-08-28 |
4 |
S |
$108.06 |
$1,190,097 |
I/I |
(11,013) |
1,110,581 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2014-08-29 |
4 |
S |
$108.15 |
$1,133,560 |
I/I |
(10,481) |
1,100,100 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2018-11-08 |
4 |
S |
$51.13 |
$2,931,583 |
I/I |
(57,339) |
1,042,761 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2018-11-09 |
4 |
S |
$50.23 |
$45,508 |
I/I |
(906) |
1,041,855 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2018-11-12 |
4 |
S |
$49.83 |
$272,980 |
I/I |
(5,478) |
1,036,377 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2018-11-15 |
4 |
S |
$47.63 |
$2,138,811 |
I/I |
(44,898) |
991,479 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2018-11-16 |
4 |
S |
$46.79 |
$1,198,775 |
I/I |
(25,600) |
965,879 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2018-11-19 |
4 |
S |
$47.08 |
$46,605 |
I/I |
(990) |
964,889 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2018-12-12 |
4 |
S |
$47.84 |
$277,803 |
I/I |
(5,807) |
959,082 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2018-12-13 |
4 |
S |
$46.18 |
$402,692 |
I/I |
(8,720) |
950,362 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2020-08-11 |
4 |
S |
$60.87 |
$6,546,747 |
I/I |
(106,772) |
843,590 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
